Roche Diagnostics UK & Ireland is part of three consortia to win government funding for projects that aim to improve patient care and early diagnosis in key disease areas, such as cancer and liver diseases.

The grants have been made through the Enabling Integrated Diagnostics for Early Detection strand of UK Research and Innovation’s Industrial Strategy Challenge Fund. The awards include projects being led by the Universities of Oxford and Manchester and Queen’s University, Belfast.

The University of Oxford’s project is the Integration and Analysis of Data using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases (DART) and focuses on lung cancer.

The Manchester project is Integrated Diagnostics for Early Diagnosis of Liver Disease (ID-LIVER) and involves a partnership between researchers from Manchester and Nottingham under the NAVIFY platform, co-developed by Roche and GE Healthcare.

Belfast’s project, The ACTIONED Consortium: integrAted moleCular soluTIons fOr diagNostics and Early Detection, involves a research collaboration between Roche, the Precision Medicine Centre of Excellence at Queen’s University Belfast and Sonrai Analytics.

Roche UK & Ireland Managing Director Geoff Twist said: “We are thrilled with these funding awards, because it gives us the opportunity to work towards ground-breaking innovation in early diagnosis and because working in partnership is vital to achieve success in the health system.”

“By bringing together the collective knowledge and expertise of these academic, medical and industry partners, these projects have the potential to impact patient care globally through new diagnostic solutions in cancer as well as thoracic and liver disease.”

Contact us


Tel: +44 (0)1424 777745

Fax: +44 (0)1424 777746



Kirkham Young Ltd.
The Old Court House
North Trade Road
East Sussex
TN33 0EX